Sep 15, 2003
Are the side effects from the powerful drug therapies permanent? That is, lipodistrophy, wasting esp. nausea just something all treated have to deal w/ or is it a matter of informed dialogue between doc and patient along w/ the increased options (new PIs,t-20, TRAIL) that are available? Thank you dearly
Response from Dr. Boyle
Some side effects, for example nausea, can be transitory and resolve while continuing therapy while others can be quite persistent, such as lipodystrophy. Still, there is some evidence that changing therapies, for example from stavudine (d4T) to abacavir, may help and some of the newer medications may have very low rates of metabolic complications and lipodystrophy. In the GS 903 trial, the regimen of efavirenz, tenofovir and lamivudine had a rate of lipodystrophy of only 1% at the end of 96 weeks of therapy, which is encouraging regarding the likelihood that rates of lipodystrophy can be improved on the regimens we are using today. Also, there is a growing amount of evidence that lipodystrophy and some other complications of therapy are related to the patients T cells when starting therapy and that higher T cells (over 350) when therapy is begun may decrease the risk of the patient encountering these problems. So, a combination of starting relatively early, with the right regimen, may limit the risk of serious complications.
Which HAART regimens are least likely to cause nausea and vomiting?
HAART therapy and Hypertension
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.